![PDF) Participating in HIV Clinical Trials: Reasons and Experiences Among Women Living With HIV in Thailand PDF) Participating in HIV Clinical Trials: Reasons and Experiences Among Women Living With HIV in Thailand](https://i1.rgstatic.net/publication/277305552_Participating_in_HIV_Clinical_Trials_Reasons_and_Experiences_Among_Women_Living_With_HIV_in_Thailand/links/5566504b08aec22682ff19cf/largepreview.png)
PDF) Participating in HIV Clinical Trials: Reasons and Experiences Among Women Living With HIV in Thailand
![Journal of Immunological Methods | Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies | ScienceDirect.com by Elsevier Journal of Immunological Methods | Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0022175914X00098-cov200h.gif)
Journal of Immunological Methods | Building Global Resource Programs to Support HIV/AIDS Clinical Trial Studies | ScienceDirect.com by Elsevier
![Suubi+Adherence Study Protocol: A family economic empowerment intervention addressing HIV treatment adherence for perinatally infected adolescents" published in Contemporary Clinical Trials Communications Journal | SMART Africa Center | Washington ... Suubi+Adherence Study Protocol: A family economic empowerment intervention addressing HIV treatment adherence for perinatally infected adolescents" published in Contemporary Clinical Trials Communications Journal | SMART Africa Center | Washington ...](https://sites.wustl.edu/smartafrica/files/2019/11/Suubi-Adherence-protocol.jpg)
Suubi+Adherence Study Protocol: A family economic empowerment intervention addressing HIV treatment adherence for perinatally infected adolescents" published in Contemporary Clinical Trials Communications Journal | SMART Africa Center | Washington ...
PLOS ONE: Obtaining Valid Laboratory Data in Clinical Trials Conducted in Resource Diverse Settings: Lessons Learned from a Microbicide Phase III Clinical Trial
![Broadening Community Engagement in Clinical Research: Designing and Assessing a Pilot Crowdsourcing Project to Obtain Community Feedback on an HIV Clinical Trial - UNC Center for Bioethics Broadening Community Engagement in Clinical Research: Designing and Assessing a Pilot Crowdsourcing Project to Obtain Community Feedback on an HIV Clinical Trial - UNC Center for Bioethics](https://bioethics.unc.edu/wp-content/uploads/sites/785/2020/02/Clinical-Trials-Journal.jpg)
Broadening Community Engagement in Clinical Research: Designing and Assessing a Pilot Crowdsourcing Project to Obtain Community Feedback on an HIV Clinical Trial - UNC Center for Bioethics
PLOS Clinical Trials: A Randomised Trial Comparing Genotypic and Virtual Phenotypic Interpretation of HIV Drug Resistance: The CREST Study
![Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows Program and the International AIDS Vaccine Initiative | BMC Health Services Research | Full Text Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows Program and the International AIDS Vaccine Initiative | BMC Health Services Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1472-6963-13-378/MediaObjects/12913_2012_Article_2823_Fig1_HTML.jpg)
Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows Program and the International AIDS Vaccine Initiative | BMC Health Services Research | Full Text
![Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial - The Lancet HIV Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial - The Lancet HIV](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/58690bd2-3e4a-401f-8bb0-1d24f8f4ddf8/gr1a_lrg.jpg)
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial - The Lancet HIV
![Disposition, by gender, of participants screened in two HIV vaccine... | Download Scientific Diagram Disposition, by gender, of participants screened in two HIV vaccine... | Download Scientific Diagram](https://www.researchgate.net/profile/Patricia-Fast/publication/49800738/figure/fig1/AS:305760220270599@1449910326012/Disposition-by-gender-of-participants-screened-in-two-HIV-vaccine-clinical-trials.png)
Disposition, by gender, of participants screened in two HIV vaccine... | Download Scientific Diagram
![Moving to Another World: Understanding the Impact of Clinical Trial Closure on Research Participants Living With HIV in Uganda | Article | NursingCenter Moving to Another World: Understanding the Impact of Clinical Trial Closure on Research Participants Living With HIV in Uganda | Article | NursingCenter](https://www.nursingcenter.com/wkhlrp/handlers/Cv.png?key=cv_00001782-201910000-00000)
Moving to Another World: Understanding the Impact of Clinical Trial Closure on Research Participants Living With HIV in Uganda | Article | NursingCenter
![Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) - The Lancet Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/323cf707-35b7-48e7-b2c3-bfce23ad91d8/gr1_lrg.gif)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) - The Lancet
![A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls - eBioMedicine A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/06e4c98b-0783-4062-908f-52e0832f391d/gr1.jpg)